Hederacolchiside A1

Cat. No.: 0225LY-0575

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Hederacolchiside A1 exhibits anti-leishmanial and antiproliferative activities by altering parasite membrane integrity; it also targets cancer cells (IC50: 2.4 μM), particularly pigmented melanoma, by inducing apoptosis via the PI3K/Akt/mTOR pathway.

Synonym: Raddeanoside R13; 106577-39-3; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2S,3R,4S,5S)-4-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-((2S,3R,4S,5S)-4-hydroxy-5-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl)oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid

CAS No.: 106577-39-3

Compound CID: 11622076

Formula: C₄₇H₇₆O₁₆

Formula Weight: 897.1

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Hederacolchiside A1 can be used in cancer biology to investigate its role in inducing apoptosis and inhibiting the PI3K/Akt/mTOR pathway.